𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Disease activity early in the course of treatment predicts response to therapy after one year in rheumatoid arthritis patients

✍ Scribed by Daniel Aletaha; Julia Funovits; Edward C. Keystone; Josef S. Smolen

Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
205 KB
Volume
56
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Five-year followup of rheumatoid arthrit
Five-year followup of rheumatoid arthritis patients after early treatment with disease-modifying antirheumatic drugs versus treatment according to the pyramid approach in the first year
✍ Suzan M. M. Verstappen; Johannes W. G. Jacobs; Johannes W. J. Bijlsma; Anton H. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 2 views

## Abstract ## Objective To evaluate whether the clinical advantages observed after 1 year in a randomized controlled clinical trial, in which 2 treatment strategies were compared (the early disease‐modifying antirheumatic drug [DMARD] approach versus the pyramid approach), persist after 5 years.

Failure of low-dose intravenous immunogl
Failure of low-dose intravenous immunoglobulin therapy to suppress disease activity in patients with treatment-refractory rheumatoid arthritis
✍ Keith S. Kanik; Cheryl H. Yarboro; Yaakov Naparstek; Paul H. Plotz; Ronald L. Wi 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 262 KB 👁 2 views

Treatment with high-dose (400 mg/kg/ day) intravenous immunoglobulin ( M g ) shows benefit in many autoimmune diseases but is very expensive. Low-dose M g has also been shown to be effective in inhibiting adjuvant arthritis in the rat. This pilot, randomized, double-blind, placebo-controlled trial w

Ability of the American College of Rheum
Ability of the American College of Rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later
✍ Alain Saraux; Jean M. Berthelot; Gérard Chalès; Catherine Le Henaff; Jean B. Tho 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 2 views

Objective. To determine how well the American College of Rheumatology (ACR; formerly, the American Rheumatism Association) 1987 classification criteria for rheumatoid arthritis (RA), when used at study inclusion in a cohort of 270 patients with early (<1 year) arthritis, predicted a diagnosis of RA

Markers for type II collagen breakdown p
Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritis
✍ Robert Landewé; Piet Geusens; Maarten Boers; Désirée van der Heijde; Willem Lems 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB 👁 1 views

## Abstract ## Objective To investigate in a randomized clinical trial setting with an aggressive combination‐therapy arm and a mild‐monotherapy arm, whether therapy‐induced changes in urinary C‐terminal crosslinking telopeptide of type I collagen (CTX‐I) and type II collagen (CTX‐II) predict 5‐ye